Search research articles
Contact Us
Filters
Showing results (141-150 of 155) with videos related to
Page
of 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 8, 2015
Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)
Christoph Mamot, Dirk Klingbiel, Felicitas Hitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2006
Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor)
Michael C Heinrich, Grant A McArthur, George D Demetri, et al.
Breast Cancer Research and Treatment
|
November 30, 2004
High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer
Gilbert Spizzo, Philip Went, Stephan Dirnhofer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2008
Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases
Michael C Heinrich, Heikki Joensuu, George D Demetri, et al.
Blood
|
November 1, 2014
Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma
Andre Weilemann, Michael Grau, Tabea Erdmann, et al.
The Journal of Clinical Investigation
|
February 8, 2019
Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms
Simona Stivala, Tamara Codilupi, Sime Brkic, et al.
Histopathology
|
May 5, 2021
Burkitt lymphoma with a granulomatous reaction: an M1/Th1-polarised microenvironment is associated with controlled growth and spontaneous regression
Massimo Granai, Stefano Lazzi, Virginia Mancini, et al.
Blood
|
January 24, 2015
DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features
Alberto J Arribas, Andrea Rinaldi, Afua A Mensah, et al.
Oncotarget
|
October 21, 2017
mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition
Gongda Xue, Reto Kohler, Fengyuan Tang, et al.
Nature
|
August 2, 2019
Publisher Correction: Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
Anna M Paczulla, Kathrin Rothfelder, Simon Raffel, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 155) with videos related to
Sort By:
Page
of 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 8, 2015
Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)
Christoph Mamot, Dirk Klingbiel, Felicitas Hitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2006
Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor)
Michael C Heinrich, Grant A McArthur, George D Demetri, et al.
Breast Cancer Research and Treatment
|
November 30, 2004
High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer
Gilbert Spizzo, Philip Went, Stephan Dirnhofer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2008
Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases
Michael C Heinrich, Heikki Joensuu, George D Demetri, et al.
Blood
|
November 1, 2014
Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma
Andre Weilemann, Michael Grau, Tabea Erdmann, et al.
The Journal of Clinical Investigation
|
February 8, 2019
Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms
Simona Stivala, Tamara Codilupi, Sime Brkic, et al.
Histopathology
|
May 5, 2021
Burkitt lymphoma with a granulomatous reaction: an M1/Th1-polarised microenvironment is associated with controlled growth and spontaneous regression
Massimo Granai, Stefano Lazzi, Virginia Mancini, et al.
Blood
|
January 24, 2015
DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features
Alberto J Arribas, Andrea Rinaldi, Afua A Mensah, et al.
Oncotarget
|
October 21, 2017
mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition
Gongda Xue, Reto Kohler, Fengyuan Tang, et al.
Nature
|
August 2, 2019
Publisher Correction: Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
Anna M Paczulla, Kathrin Rothfelder, Simon Raffel, et al.
Page
of 16